AAAAAA
Results: 1-25/31
Authors:
NAU R
SORGEL F
PRANGE HW
Citation: R. Nau et al., PHARMACOKINETIC OPTIMIZATION OF THE TREATMENT OF BACTERIAL CENTRAL-NERVOUS-SYSTEM INFECTIONS, Clinical pharmacokinetics, 35(3), 1998, pp. 223-246
Authors:
TUMANI H
REIBER H
NAU R
PRANGE HW
KAUFFMANN K
MADER M
FELGENHAUER K
Citation: H. Tumani et al., BETA-TRACE PROTEIN-CONCENTRATION IN CEREBROSPINAL-FLUID IS DECREASED IN PATIENTS WITH BACTERIAL-MENINGITIS, Neuroscience letters, 242(1), 1998, pp. 5-8
Authors:
NAU R
LASSEK C
KINZIGSCHIPPERS M
THIEL A
PRANGE HW
SORGEL F
Citation: R. Nau et al., DISPOSITION AND ELIMINATION OF MEROPENEM IN CEREBROSPINAL-FLUID OF HYDROCEPHALIC PATIENTS WITH EXTERNAL VENTRICULOSTOMY, Antimicrobial agents and chemotherapy, 42(8), 1998, pp. 2012-2016
Authors:
HAUPT WF
PRANGE HW
JANZEN RWC
Citation: Wf. Haupt et al., POSTANOXIC COMA AND PROGNOSIS, Anaesthesist, 47(8), 1998, pp. 682-684
Authors:
HAUPT WF
JANZEN RWC
PRANGE HW
Citation: Wf. Haupt et al., POSTANOXIC COMA - SYMPTOMATOLOGY AND PROG NOSIS - LITERATURE-REVIEW AND POSITION PAPER - REPLY, Aktuelle Neurologie, 24(5), 1997, pp. 228-228
Authors:
HAUPT WF
PRANGE HW
JANZEN RWC
Citation: Wf. Haupt et al., POSTANOXIC COMA - CLINICAL-DATA AND PROGN OSIS, REVIEW OF LITERATURE AND STATE-OF-THE-ART, Aktuelle Neurologie, 24(3), 1997, pp. 103-109
Authors:
PRANGE HW
NAU R
Citation: Hw. Prange et R. Nau, DIAGNOSIS AND TREATMENT OF BRAIN-ABSCESS, Aktuelle Neurologie, 24(2), 1997, pp. 84-89
Authors:
SCHUNEMANN S
WERNER GS
SCHULZ R
BITSCH A
PRANGE HW
KREUZER H
Citation: S. Schunemann et al., EMBOLIC COMPLICATIONS IN INFECTIVE ENDOCA RDITIS, Zeitschrift fur Kardiologie, 86(12), 1997, pp. 1017-1025
Authors:
PRANGE HW
NAU R
Citation: Hw. Prange et R. Nau, PHARMACODYNAMICS AND PHARMACOKINETICS OF OSMOTHERAPEUTIC AGENTS IN INTRACRANIAL HYPERTENSION, Anasthesiologie und Intensivmedizin, 38(7-8), 1997, pp. 417-422
KINETICS OF PIPERACILLIN AND TAZOBACTAM IN VENTRICULAR CEREBROSPINAL-FLUID OF HYDROCEPHALIC PATIENTS
Authors:
NAU R
KINZIGSCHIPPERS M
SORGEL F
SCHINSCHKE S
ROSSING R
MULLER C
KOLENDA H
PRANGE HW
Citation: R. Nau et al., KINETICS OF PIPERACILLIN AND TAZOBACTAM IN VENTRICULAR CEREBROSPINAL-FLUID OF HYDROCEPHALIC PATIENTS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 987-991
Authors:
NAU R
DESEL A
LASSEK C
THIEL A
SCHINSCHKE S
ROSSING R
KOLENDA H
PRANGE HW
Citation: R. Nau et al., SLOW ELIMINATION OF MANNITOL FROM HUMAN CEREBROSPINAL-FLUID, European Journal of Clinical Pharmacology, 53(3-4), 1997, pp. 271-274
Authors:
DIEDRICH U
BITSCH A
EICKE M
RATHGEBER J
PRANGE HW
Citation: U. Diedrich et al., GAMMA-HYDROXYBUTYRATE IN THE TREATMENT OF INCREASED INTRACRANIAL-PRESSURE AND VASOSPASM, Aktuelle Neurologie, 23(2), 1996, pp. 63-67
Authors:
NAU R
PRANGE HW
KINZIG M
FRANK A
DRESSEL A
SCHOLZ P
KOLENDA H
SORGEL F
Citation: R. Nau et al., CEREBROSPINAL-FLUID CEFTAZIDIME KINETICS IN PATIENTS WITH EXTERNAL VENTRICULOSTOMIES, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 763-766
ESTIMATION OF STEADY-STATE ANTIBIOTIC CONCENTRATION IN CEREBROSPINAL-FLUID FROM SINGLE-DOSE KINETICS
Authors:
NAU R
PRANGE HW
Citation: R. Nau et Hw. Prange, ESTIMATION OF STEADY-STATE ANTIBIOTIC CONCENTRATION IN CEREBROSPINAL-FLUID FROM SINGLE-DOSE KINETICS, European Journal of Clinical Pharmacology, 49(5), 1996, pp. 407-409
Authors:
ZYSK G
BRUCK W
GERBER J
BRUCK Y
PRANGE HW
NAU R
Citation: G. Zysk et al., ANTIINFLAMMATORY TREATMENT INFLUENCES NEURONAL APOPTOTIC CELL-DEATH IN THE DENTATE GYRUS IN EXPERIMENTAL PNEUMOCOCCAL MENINGITIS, Journal of neuropathology and experimental neurology, 55(6), 1996, pp. 722-728
Authors:
NAU R
SORGEL F
PRANGE HW
Citation: R. Nau et al., PASSIVE TRANSFER OF LOW-MOLECULAR COMPOUNDS INTO HUMAN CSF IS GOVERNED BY LIPOPHILICITY, MOLECULAR-SIZE, AND PROTEIN-BINDING, Journal of neurochemistry, 66, 1996, pp. 25-25
Authors:
RIECKMANN P
SCHOLZE G
WEICHSELBRAUN I
GANAPATI R
PRANGE HW
Citation: P. Rieckmann et al., SOLUBLE ADHESION MOLECULES IN SERA OF PATIENTS WITH LEPROSY - LEVELS OF SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 (SICAM-1) RAPIDLY DECREASE DURING MULTIDRUG THERAPY, Clinical and experimental immunology, 105(1), 1996, pp. 65-68
Authors:
BITSCH A
NAU R
HILGERS RA
VERHEGGEN R
WERNER G
PRANGE HW
Citation: A. Bitsch et al., FOCAL NEUROLOGIC DEFICITS IN INFECTIVE ENDOCARDITIS AND OTHER SEPTIC DISEASES, Acta neurologica Scandinavica, 94(4), 1996, pp. 279-286
Authors:
NAU R
ZYSK G
REINERT RR
MERGERYAN H
EIFFERT H
PRANGE HW
Citation: R. Nau et al., ACTIVITY OF FOSFOMYCIN IN A RABBIT MODEL OF EXPERIMENTAL PNEUMOCOCCALMENINGITIS, Journal of antimicrobial chemotherapy, 36(6), 1995, pp. 997-1004
Authors:
NAU R
PRANGE HW
Citation: R. Nau et Hw. Prange, LABOR DIAGNOSIS IN INFECTIONS OF THE CENT RAL-NERVOUS-SYSTEM, Der Internist, 36(2), 1995, pp. 158-161
Authors:
PRANGE HW
Citation: Hw. Prange, PATHOPHYSIOLOGY, TREATMENT AND PROGNOSIS OF CEREBRAL HYPOXIC-ISCHEMICBRAIN-DAMAGE, Zeitschrift fur Kardiologie, 83, 1994, pp. 127-134
Authors:
NAU R
KINZIG M
DREYHAUPT T
KOLENDA H
SORGEL F
PRANGE HW
Citation: R. Nau et al., KINETICS OF OFLOXACIN AND ITS METABOLITES IN CEREBROSPINAL-FLUID AFTER A SINGLE INTRAVENOUS-INFUSION OF 400 MILLIGRAMS OF OFLOXACIN, Antimicrobial agents and chemotherapy, 38(8), 1994, pp. 1849-1853
Authors:
SCHAARSCHMIDT H
PRANGE HW
REIBER H
Citation: H. Schaarschmidt et al., NEURON-SPECIFIC ENOLASE CONCENTRATIONS IN BLOOD AS A PROGNOSTIC PARAMETER IN CEREBROVASCULAR DISEASES, Stroke, 25(3), 1994, pp. 558-565
Authors:
NAU R
THIEL A
PRANGE HW
Citation: R. Nau et al., LIFE-THREATENING EMBOLISM BY CENTRAL VENO US CATHETER FRAGMENTS IN PSYCHIATRIC-PATIENTS, Nervenarzt, 65(5), 1994, pp. 350-352
Authors:
THIEL A
NAU R
WILLERS T
RUTHER E
PRANGE HW
Citation: A. Thiel et al., INTENSIVE-CARE MEASURES IN PSYCHIATRIC-IN PATIENTS, Nervenarzt, 65(3), 1994, pp. 183-190